Men's Health
New tests promise smarter prostate cancer screening and treatment
The prostate-specific antigen (PSA) test is widely used to check otherwise healthy men for signs of hidden prostate cancer. But PSA screening remains controversial because it often leads to men being "overdiagnosed" with slow-growing tumors that might never have harmed their health or shortened their lives. Many men seek treatment anyway, potentially exposing themselves to risks such as erectile dysfunction and urinary problems for uncertain benefit.
To continue reading this article, you must log in.
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.
- Research health conditions
- Check your symptoms
- Prepare for a doctor's visit or test
- Find the best treatments and procedures for you
- Explore options for better nutrition and exercise
I'd like to receive access to Harvard Health Online for only $4.99 a month.
Sign Me UpAlready a member? Login ».
Disclaimer:
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.
